Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Serum biomarkers for heart failure.

Petr Jarolim1

  • 1Department of Pathology, Division of Clinical Laboratories, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA. pjarolim@partners.org

Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology
|May 16, 2006
PubMed
Summary

Biomarkers like B-type natriuretic peptide (BNP) and NT-proBNP help predict heart failure outcomes. Research continues to find new markers for better patient monitoring and therapy guidance.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The actively secreted plasma extracellular vesicle troponin (ASPECT) study: circulating troponin in extracellular vesicles across cardiovascular disease cohorts.

Biomarker research·2026
Same author

Acute Febrile Illness Surveillance for Estimating Population Immunity, Dominican Republic, 2021.

Emerging infectious diseases·2026
Same author

Endothelin-1 and Cardio-Kidney Events among Patients with Chronic Kidney Disease, Diabetes, and Anemia.

American journal of nephrology·2025
Same author

Transpulmonary Proteome Gradients Identify Pathways Involved in Pulmonary Vascular Disease Due To Heart Failure.

Circulation. Heart failure·2025
Same author

Galectin-3 and kidney function in type 2 diabetes treated with dapagliflozin: Analysis from DECLARE-TIMI 58.

ESC heart failure·2025
Same author

Growth Differentiation Factor-15 and the Effect of Dapagliflozin in Heart Failure: Insights From the DAPA-HF Trial.

Journal of cardiac failure·2025

Area of Science:

  • Cardiology
  • Biomarker Discovery

Background:

  • Heart failure incidence is rising globally.
  • High readmission rates in acute decompensated heart failure necessitate predictive biomarkers.
  • Current biomarkers include B-type natriuretic peptide (BNP) and NT-proBNP, with others like atrial natriuretic peptide and endothelin-1 used in research.

Purpose of the Study:

  • To identify and evaluate biomarkers for predicting the clinical course of heart failure.
  • To explore biomarkers for monitoring heart failure patients and guiding therapy.
  • To highlight the importance of developing novel biomarkers for improved diagnosis and treatment.

Main Methods:

  • Review of existing literature on heart failure biomarkers.
  • Analysis of the clinical utility of BNP and NT-proBNP.

Related Experiment Videos

  • Discussion of research-stage biomarkers such as atrial natriuretic peptide and endothelin-1.

    • Main Results:

    • BNP and NT-proBNP are established and frequently used analytes for heart failure.
    • Atrial natriuretic peptide and endothelin-1 show potential but are primarily used in research settings.
    • The search for additional biomarkers is ongoing.

    Conclusions:

    • BNP and NT-proBNP are crucial for managing heart failure patients.
    • Further biomarker development is essential for advancing the diagnosis and treatment of both chronic and acute decompensated heart failure.